Amersin Subsidiary Receives 30 Million RMB Contract

Amersin Life Science Corporation announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Company, has been awarded a 30 million RMB sales contract (approximately $3.6 million) to supply a range of homeostatic, antiviral and other pharmaceuticals in injectable form to Hubei Jiuzhoutong Pharmaceutical. Hubei Jiuzhoutong Pharmaceutical Ltd. is one of the largest and the fastest growing privately owned pharmaceutical distribution companies in China. It has established sales and distribution networks throughout China.

Yahoo News (http://uk.biz.yahoo.com/050406/290/ffs7x.html)